Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Paulden

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual ModelDaniel D H Howdon, James R S Lomas, Mike Paulden
Gaceta Sanitaria|March 7, 2025
The opportunity cost of funding new medicines: an attempt to measure the invisibleLaura Vallejo-Torres, David J Vanness, Mike Paulden, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 5, 2021
Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trialNathan S McClure, Mike Paulden, Arto Ohinmaa, et al.
Economics and Human Biology|May 23, 2020
The health and financial impacts of a sugary drink tax across different income groups in CanadaKai-Erh Kao, Amanda C Jones, Arto Ohinmaa, et al.
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 9, 2022
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount RatesAnkur Pandya, Mike Paulden, Jinyi Zhu, et al.
Disability and Rehabilitation|October 31, 2020
Quality of reporting of economic evaluations in rehabilitation research: a systematic reviewJulie Flemming, Dagmara Chojecki, Lisa Tjosvold, et al.
Health Economics|December 15, 2010
Discounting and decision making in the economic evaluation of health-care technologiesKarl Claxton, Mike Paulden, Hugh Gravelle, et al.
Journal of Clinical Epidemiology|November 5, 2021
Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondentsNathan S McClure, Feng Xie, Mike Paulden, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 21, 2019
Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual ModelDaniel D H Howdon, James R S Lomas, Mike Paulden
Gaceta Sanitaria|March 7, 2025
The opportunity cost of funding new medicines: an attempt to measure the invisibleLaura Vallejo-Torres, David J Vanness, Mike Paulden, et al.
Pharmacoeconomics|August 23, 2014
Some inconsistencies in NICE's consideration of social valuesMike Paulden, James F O'Mahony, Anthony J Culyer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 5, 2021
Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trialNathan S McClure, Mike Paulden, Arto Ohinmaa, et al.
Economics and Human Biology|May 23, 2020
The health and financial impacts of a sugary drink tax across different income groups in CanadaKai-Erh Kao, Amanda C Jones, Arto Ohinmaa, et al.
Pharmacoeconomics|December 17, 2019
One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net BenefitChristopher McCabe, Mike Paulden, Isaac Awotwe, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|May 9, 2022
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount RatesAnkur Pandya, Mike Paulden, Jinyi Zhu, et al.
Disability and Rehabilitation|October 31, 2020
Quality of reporting of economic evaluations in rehabilitation research: a systematic reviewJulie Flemming, Dagmara Chojecki, Lisa Tjosvold, et al.
Health Economics|December 15, 2010
Discounting and decision making in the economic evaluation of health-care technologiesKarl Claxton, Mike Paulden, Hugh Gravelle, et al.
Journal of Clinical Epidemiology|November 5, 2021
Small differences in EQ-5D-5L health utility scores were interpreted differently between and within respondentsNathan S McClure, Feng Xie, Mike Paulden, et al.
Pageof 8